155 related articles for article (PubMed ID: 2478475)
1. Expression of tetanus toxin subfragments in vitro and characterization of epitopes.
Andersen-Beckh B; Binz T; Kurazono H; Mayer T; Eisel U; Niemann H
Infect Immun; 1989 Nov; 57(11):3498-505. PubMed ID: 2478475
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
Boucher P; Sato H; Sato Y; Locht C
Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
[TBL] [Abstract][Full Text] [Related]
3. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tetanus toxin fragment C binding to ganglioside G(T1b) by monoclonal antibodies recognizing different epitopes.
Fitzsimmons SP; Clark KC; Wilkerson R; Shapiro MA
Vaccine; 2000 Aug; 19(1):114-21. PubMed ID: 10924793
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.
Luo P; Qin L; Mao X; Chen L; Yu S; Li Q; Liu W; Zhang W; Gu J; Zou Q
Vaccine; 2012 Oct; 30(45):6449-55. PubMed ID: 22889825
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of monoclonal antibodies to tetanus toxin.
Sheppard AJ; Cussell D; Hughes M
Infect Immun; 1984 Feb; 43(2):710-4. PubMed ID: 6198285
[TBL] [Abstract][Full Text] [Related]
8. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
[TBL] [Abstract][Full Text] [Related]
9. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case.
Saikh KU; Sesno J; Brandler P; Ulrich RG
Vaccine; 1998; 16(9-10):1029-38. PubMed ID: 9682355
[TBL] [Abstract][Full Text] [Related]
10. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
11. Efficient production of complement (C3d)3 fusion proteins using the baculovirus expression vector system.
Barrault DV; Steward M; Cox VF; Smith RA; Knight AM
J Immunol Methods; 2005 Sep; 304(1-2):158-73. PubMed ID: 16109422
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of functional fragment C of tetanus toxin.
Halpern JL; Habig WH; Neale EA; Stibitz S
Infect Immun; 1990 Apr; 58(4):1004-9. PubMed ID: 2318526
[TBL] [Abstract][Full Text] [Related]
13. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptide antigens of tetanus toxin.
Fischer PM; Howden ME
Mol Immunol; 1994 Oct; 31(15):1141-8. PubMed ID: 7935502
[TBL] [Abstract][Full Text] [Related]
15. Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus.
Stratford R; Douce G; Zhang-Barber L; Fairweather N; Eskola J; Dougan G
Vaccine; 2000 Nov; 19(7-8):810-5. PubMed ID: 11115703
[TBL] [Abstract][Full Text] [Related]
16. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
[TBL] [Abstract][Full Text] [Related]
17. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
[TBL] [Abstract][Full Text] [Related]
18. A novel and simple procedure for determining T cell epitopes in protein antigens.
Demotz S; Matricardi P; Lanzavecchia A; Corradin G
J Immunol Methods; 1989 Aug; 122(1):67-72. PubMed ID: 2474615
[TBL] [Abstract][Full Text] [Related]
19. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
[TBL] [Abstract][Full Text] [Related]
20. A simplified method for the preparation of tetanus toxin binding fragment for neurobiology.
Fishman PS; Farrand DA; Halpern JL; Latham WC
J Neurosci Methods; 1992 May; 42(3):229-36. PubMed ID: 1380109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
